Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

161.

Diagnostic criteria for nonviable pregnancy early in the first trimester.

N. Engl. J. Med.
Doubilet PM, Benson CB, Bourne T, Blaivas M, Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE.
| Oct 10, 2013
162.

No easy fixes.

N. Engl. J. Med.
Taqueti VR.
| Oct 10, 2013
163.

Training physicians to manage obesity--back to the drawing board.

N. Engl. J. Med.
Colbert JA, Jangi S.
| Oct 10, 2013
164.

PEPFAR in transition--implications for HIV care in South Africa.

N. Engl. J. Med.
Katz IT, Bassett IV, Wright AA.
| Oct 10, 2013
165.

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

JAMA.
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB.
| Oct 2, 2013
166.

CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

N. Engl. J. Med.
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H, Boeckh M, Marty F.
| Sep 26, 2013
168.

Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.

Proc. Natl. Acad. Sci. U.S.A.
McLaughlin-Drubin ME, Park D, Munger K.
| Oct 1, 2013
169.

Balancing AMCs' missions and health care costs--mission impossible?

N. Engl. J. Med.
Nabel EG, Ferris TG, Slavin PL.
| Sep 12, 2013
170.

Primate genome architecture influences structural variation mechanisms and functional consequences.

Proc. Natl. Acad. Sci. U.S.A.
Gokcumen O, Tischler V, Tica J, Zhu Q, Iskow RC, Lee E, Fritz MH, Langdon A, Stütz AM, Pavlidis P, Benes V, Mills RE, Park PJ, Lee C, Korbel JO.
| Sep 24, 2013
172.

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.

Lancet.
Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA.
| Dec 14, 2013
173.

Sphingolipids and susceptibility to asthma.

N. Engl. J. Med.
Levy BD.
| Sep 5, 2013
174.

Clinical problem-solving. A patient with syncope.

N. Engl. J. Med.
Fox MC, Lakdawala N, Miller AL, Loscalzo J.
| Sep 5, 2013
175.

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Nat. Immunol.
Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ.
| 09 01, 2013
176.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

N. Engl. J. Med.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, Braunwald E.
| Oct 3, 2013
178.

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.

Lancet.
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL.
| Aug 17, 2013
179.

A trial-based approach to statin guidelines.

JAMA.
Ridker PM, Wilson PW.
| Sep 18, 2013
180.

Who is now responsible for discovering and warning about adverse effects of generic drugs?

JAMA.
Kesselheim AS, Green MD, Avorn J.
| Sep 11, 2013